Wikidata

(Q95381194)

English

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial

No description defined

In more languages
default values for all languages
No label defined

No description defined

Statements

title
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24852788
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852788%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 May 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q95381194&oldid=2075024385"